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Accumulating evidence suggests that the aberrant taxonomic composition 
of gut microbiota is one of the etiological factor in the development of 
obesity. With the inherent plasticity of gut microbiota structure, it provides 
a new avenue for the application of biotherapeutics to modulate the shifted 
structure of microbiota in obesity. Lately, much attention has been focused on 
probiotic as a biotherapeutics candidate for obesity. In contrast, knowledge 
on the modulating effects of probiotic on the obese gut microbiota structure 
is still limited and should be evaluated. The present study aims to elucidate 
the inherent plasticity of gut microbiota and the dynamic response of the host
metabolism during the induction of high-fat-diet-induced obesity and upon 
the amelioration of obesity by probiotics in obese rat models. Two probiotic 
candidates; (i) single strain Lactobacillus casei strain Shirota (LAB13) 
and (ii) probiotic cocktail LACTO-5™ (L. rhamnosus, L. acidophilus, B. 
subtilis, B. longum and S. thermophilus) were supplemented to the obese rats 
at doses of 1 ×109 CFU per/day/rat for 12 weeks. The probiotic treatment 
started after the induction of obesity using high fat diet (HFD, 60% fat). 
The heterogeneity of gut microbiota structure and its functional complement 
genes were profiled from the faecal samples of rats from each intervention 
group (n=3/group) using shotgun metagenomics sequencing. Phenotypically, 
the weight gain, energy intake, subcutaneous fat, total fat weights, total 
cholesterol, leptin, ratio of TC to HDL-c and leptin to adiponectin in obese 
rats were significantly reduced by the supplementation of both probiotics. 
These confirmed the anti-obesity, hypocholesterolemic and hypoleptinemia 
effects of both probiotics. The strain-specific salutary effect was noted in 
the reduction of TG and ratio of TG to HDL-c by LAB13. Both probiotics 
shifted the HFD-modulated gut microbiota towards the lean structure after 
Muntingia calabura (Muntingiaceae) is known as ‘kerukup siam’ or ‘pokok 
buah ceri’ locally. It has been used in Southeast Asia and tropical America 
as antipyretic, antiseptic, analgesic, antispasmodic and liver tonic. This study 
aims to determine the safety and the metabolic pathways involved in the 
hepatoprotective mechanism of M. calabura. Phytochemical analysis of the 
extract was carried out. The standardization of the extracts was done using 
LCMS Q-TOF. The standardized extract was subjected to acute and repeated 
doses of 28-day oral toxicity study. Three different in-vivo hepatotoxic models 
which are CCl4-induced, PCM-induced and alcohol-induced were eveloped 
and a dose dependent hepatoprotective effect of M. calabura (100 mg/kg, 
200 mg/kg and 400 mg/kg) was conducted. Body weight, food and water 
consumption were measured every day and rats were sacrificed to collect 
the serum samples at the end of the 10-days treatment for CCl4 and PCM 
induced hepatotoxic rats while samples were collected at the end of 22-days 
for alcohol-induced hepatotoxic rats. Histopathological study of the liver slice 
was carried out to confirm the hepatoprotective activity of the extract. Liquid 
chromatography-mass spectrometry quadrapole time of flight (LC/MS-QTOF) 
combined with principal component analysis (PCA) were used to determine 
differentially expressed metabolites due to treatment with hepatoxicant and 
the supplementation being given seven weeks after the induction of obesity. 
Comparative analysis revealed that the abundances of 68 bacterial genera 
were altered by HFD and probiotics. HFD uniquely modulated 21 genera, 
17 of which were promoted and positively correlated with at least one of 
the obese phenotypes in obese control rats. Thus, these genera may be 
relevant to obesity. LAB13 modulated 32 genera, the enrichment of 16 
genera of which were correlated positively with the ameliorated obese 
phenotypes. LACTO-5™ modulated five genera, of this, the enrichment 
of genus Coxiella was positively correlated with the ameliorated obese 
phenotypes. Out of this, three genera were also found reduced by LAB13. 
Theoccurrences of 13 out of 26 annotated functional categories were 
enriched in the HFD modulated gut microbiome; suggesting a relative higher 
metabolic capacity in the obese gut microbiome. Whereas both probiotic-
modulated and STD-modulated gut microbiome had lower occurrences of 
several protein-coding genes for metabolism of carbohydrate, lipids, and 
nutrient transport; suggesting a relative lower energy harvesting capacity 
in comparison to the HFD microbiome. Metabolomics analysis showed 
increment in bile acid synthesis and reduction in glycerophospholipid and 
fatty acids metabolism after probiotic treatment. These had increased the 
lipid clearance in body which improved the obese phenotypes. Results from 
this study suggest the salutary effects of probiotic, in part, are mediated by 
the changes in the gut microbiota structure and its metabolic capacities in 
host metabolism particularly bile acid biosynthesis. This study proved the 
possible mechanistic links between gut microbial-host interactions and
its role in obesity.
M. calabura extracts. Metabolomics Pathway Analysis (MetPA) was used 
for analysis and visualization of the pathways involved. This study shows 
that the body weight, food and water consumption were significantly 
decreased and histopathological study revealed liver damage in all in-vivo 
models of hepatotoxic rats. PCA score plots of the hepatotoxic rats clustered 
separately from the control, while groups given pre-treatment with the extract 
clustered closely with the control. This indicates that the metabolic profiles 
from the groups which were given pre-treatment with the extract were 
almost similar to those of the control. Several candidate biomarkers were 
identified and they were associated with perturbations of    major pathways 
involve in inflammation. Interestingly, all the potential biomarkers were 
reversed to almost normal level in the group given pre-treatment with the 
extract. This study has successfully isolated major pathways involved in 
the hepatoprotective effects of MCME using LCMS Q-TOF metabolomics 
approach. Several biomarkers and their pathways in hepatoprotection have 
not been reported previously and may provide potential therapeutic targets 
and/or options for protection from chemical induced liver injury.
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